Stockreport

New Precision Oncology Tests to Drive Personalised Therapies and Improved Treatment Outcomes

Genetic Technologies Ltd - American Depositary Shares  (GENE) 
US:NASDAQ Investor Relations: gtgcorporate.com/investor-centre
PDF MELBOURNE, Australia, April 17, 2024 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GTG”), a global leader in genomics-based tes [Read more]